Tap a claim on the ring to put it at the centre.
← The biopharma industry is structured to focus on only a limited number of disease areas.
17 connected korrents · 15 moments from 8 Mar 2012 to 5 Nov 2026.
Everything filed under infrastructure
infrastructure
Everything filed under innovation
innovation
Everything filed under creativity
creativity
Everything filed under LLMs
LLMs
Everything filed under capitalism
capitalism
Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject
Read this korrent: The biopharma industry is structured to focus on only a limited number of disease areas.
The biopharma industry is structured to focus on only a limited number of disease areas.
Last stated 2 years ago
20 May 2025
EG
Elad Gil — holds since 2025-05-20 — tap for who they are
Same subject: Drug companies pile onto the same few already-validated targets, so far less of biology gets explored than could be. — tap to centre the map on it
Drug companies pile onto the same few already-validated targets, so far less of biology gets explored than could be.
Last stated 4 months ago
21 Jul 2026
RT
Ruxandra Teslo — holds since 2026-07-21 — tap for who they are
Same subject: AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech. — tap to centre the map on it
AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech.
Last stated 12 months ago
23 Nov 2025
EH
Elliot Hershberg — holds since 2025-11-23 — tap for who they are
Same subject: Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them. — tap to centre the map on it
Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them.
Last stated 15 years ago
8 Mar 2012
DL
Derek Lowe — holds since 2012-03-08 — tap for who they are
Same subject: When pharmaceutical companies act as top-down gatekeepers for which therapeutic ideas get pursued, promising innovations from startups can be overlooked. — tap to centre the map on it
When pharmaceutical companies act as top-down gatekeepers for which therapeutic ideas get pursued, promising innovations from startups can be overlooked.
Last stated 7 months ago
12 Apr 2026
EH
Elliot Hershberg — holds since 2026-04-12 — tap for who they are
Same subject: Infectious diseases get far less industry R&D per death than non-communicable ones, because they mostly kill people in countries where a cure pays less. — tap to centre the map on it
Infectious diseases get far less industry R&D per death than non-communicable ones, because they mostly kill people in countries where a cure pays less.
Last stated a year ago
29 May 2025
JT
Jacob Trefethen — holds since 2025-05-29 — tap for who they are
Same subject: The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom. — tap to centre the map on it
The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom.
Last stated 2 years ago
16 Feb 2025
EH
Elliot Hershberg — holds since 2025-02-16 — tap for who they are
Same subject: Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated. — tap to centre the map on it
Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated.
Last stated 7 months ago
12 Apr 2026
EH
Elliot Hershberg — holds since 2026-04-12 — tap for who they are
Same subject: The pharmaceutical productivity crisis has no single villain: nearly every part of discovery and development got gradually harder and more expensive at once. — tap to centre the map on it
The pharmaceutical productivity crisis has no single villain: nearly every part of discovery and development got gradually harder and more expensive at once.
Last stated 3 years ago
23 Dec 2023
AT
Alex Telford — holds since 2023-12-23 — tap for who they are
Same subject: "Food from thin air" is not from thin air: it runs on water, minerals, ammonia and industrial plant. — tap to centre the map on it
"Food from thin air" is not from thin air: it runs on water, minerals, ammonia and industrial plant.
Last stated 5 months ago
30 Jun 2026
CS
Chris Smaje — holds since 2026-06-30 — tap for who they are
Same subject: A city's first rail line comes in at a reasonable cost and every line after it does not, because the follow-up outgrows the in-house team that oversaw the pilot. — tap to centre the map on it
A city's first rail line comes in at a reasonable cost and every line after it does not, because the follow-up outgrows the in-house team that oversaw the pilot.
Last stated 2 years ago
7 Dec 2024
AL
Alon Levy — holds since 2024-12-07 — tap for who they are
Same subject: A developer-friendly abstraction can cause severe pain at the infrastructure level. — tap to centre the map on it
A developer-friendly abstraction can cause severe pain at the infrastructure level.
Last stated 2 weeks ago
5 Nov 2026
GO
Gergely Orosz — holds since 2026-11-05 — tap for who they are
Same subject: "Return on tokens" has the same measurement problems as hours and capacity: it still hinges on a theory of value. — tap to centre the map on it
"Return on tokens" has the same measurement problems as hours and capacity: it still hinges on a theory of value.
Last stated 3 months ago
17 Aug 2026
JC
John Cutler — holds since 2026-08-17 — tap for who they are
Same subject: A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI. — tap to centre the map on it
A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI.
Last stated 11 months ago
1 Jan 2026
JL
Jason Lemkin — holds since 2026-01-01 — tap for who they are
Same subject: A base model is essentially a very expensive autocomplete that continues text according to the statistics of its training documents. — tap to centre the map on it
A base model is essentially a very expensive autocomplete that continues text according to the statistics of its training documents.
Last stated 2 years ago
5 Feb 2025
AK
Andrej Karpathy — holds since 2025-02-05 — tap for who they are
Same subject: A contest between five paid firms is not the way to get good creative work. — tap to centre the map on it
A contest between five paid firms is not the way to get good creative work.
Last stated 3 months ago
14 Aug 2026
SK
Susan Kare — holds since 2026-08-14 — tap for who they are
Same subject: A culture that is uncompromising but also kind and supportive is the most fertile ground for creativity. — tap to centre the map on it
A culture that is uncompromising but also kind and supportive is the most fertile ground for creativity.
Last stated 7 months ago
12 Apr 2026
ES
Evan Spiegel — holds since 2026-04-12 — tap for who they are
Same subject: A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them — tap to centre the map on it
A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them
IA
Isaac Asimov — holds since c. 1959 — tap for who they are
same subject or similar wording a cloud: claims about one subject, named for it bar: when it was last stated, on a scale from 2012 to today (stretched back to the oldest claim here) — full is today a face: someone who holds the claim — tap it for who they are
At the centre
The biopharma industry is structured to focus on only a limited number of disease areas.
Last stated 20 May 2025 · 2 years ago
Holds Elad Gil
Read this korrent →
Similar wording
Drug companies pile onto the same few already-validated targets, so far less of biology gets explored than could be.
Last stated 21 Jul 2026 · 4 months ago
Holds Ruxandra Teslo
Similar wording
AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech.
Last stated 23 Nov 2025 · 12 months ago
Holds Elliot Hershberg
Similar wording
Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them.
Last stated 8 Mar 2012 · 15 years ago
Holds Derek Lowe
Similar wording
When pharmaceutical companies act as top-down gatekeepers for which therapeutic ideas get pursued, promising innovations from startups can be overlooked.
Last stated 12 Apr 2026 · 7 months ago
Holds Elliot Hershberg
Similar wording
Infectious diseases get far less industry R&D per death than non-communicable ones, because they mostly kill people in countries where a cure pays less.
Last stated 29 May 2025 · a year ago
Holds Jacob Trefethen
Similar wording
The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom.
Last stated 16 Feb 2025 · 2 years ago
Holds Elliot Hershberg
Similar wording
Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated.
Last stated 12 Apr 2026 · 7 months ago
Holds Elliot Hershberg
Similar wording
The pharmaceutical productivity crisis has no single villain: nearly every part of discovery and development got gradually harder and more expensive at once.
Last stated 23 Dec 2023 · 3 years ago
Holds Alex Telford
Same subject: infrastructure
"Food from thin air" is not from thin air: it runs on water, minerals, ammonia and industrial plant.
Last stated 30 Jun 2026 · 5 months ago
Holds Chris Smaje
Same subject: infrastructure
A city's first rail line comes in at a reasonable cost and every line after it does not, because the follow-up outgrows the in-house team that oversaw the pilot.
Last stated 7 Dec 2024 · 2 years ago
Holds Alon Levy
Same subject: infrastructure
A developer-friendly abstraction can cause severe pain at the infrastructure level.
Last stated 5 Nov 2026 · 2 weeks ago
Holds Gergely Orosz
Same subject: LLMs
"Return on tokens" has the same measurement problems as hours and capacity: it still hinges on a theory of value.
Last stated 17 Aug 2026 · 3 months ago
Holds John Cutler
Same subject: LLMs
A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI.
Last stated 1 Jan 2026 · 11 months ago
Holds Jason Lemkin
Same subject: LLMs
A base model is essentially a very expensive autocomplete that continues text according to the statistics of its training documents.
Last stated 5 Feb 2025 · 2 years ago
Holds Andrej Karpathy
Same subject: creativity
A contest between five paid firms is not the way to get good creative work.
Last stated 14 Aug 2026 · 3 months ago
Holds Susan Kare
Same subject: creativity
A culture that is uncompromising but also kind and supportive is the most fertile ground for creativity.
Last stated 12 Apr 2026 · 7 months ago
Holds Evan Spiegel
Same subject: creativity
A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them
Last stated c. 1959
Holds Isaac Asimov